FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386388908> ?p ?o ?g. }

• W4386388908 abstract "With increased success, ovarian tissue cryopreservation has recently become a standard technique for fertility preservation. However, malignant cell introduction through ovarian tissue transplantation remains a major concern for patients with acute leukemias.This study aimed to investigate the safety of performing autologous ovarian tissue transplantation in survivors of acute leukemia.Clinical, histopathological, and molecular data of 4 women with acute myeloid leukemia and 2 women with acute lymphoblastic leukemia who underwent ovarian tissue cryopreservation and transplantation were analyzed in this case series. Following cryopreservation of 66% to 100% of an ovarian cortex with a slow freezing method, all women received high-dose multiagent alkylating preconditioning chemotherapy for allogeneic hematopoietic stem cell transplantation. Before the ovarian tissue transplantation, (1) antral follicle counts, serum antimüllerian hormone and follicle-stimulating hormone levels were assessed to confirm primary ovarian insufficiency; (2) all recipients were cleared by their hematologist-oncologists; (3) representative cortical strips were screened for leukemia infiltration by histologic (hematoxylin and eosin staining), immunohistochemical (CD3, CD20, CD34, CD68, CD117, CD163, PAX-5, Tdt, lysozyme, and MPO), and molecular marker evaluation (BCR/ABL p190 and AML1/ETO) where appropriate.The median age was 20 years (interquartile range, 15-32) at ovarian tissue cryopreservation. Before undergoing hematopoietic stem cell transplantation, all patients received induction or consolidation chemotherapy that included cytarabine + daunorubicin or Berlin-Frankfurt-Munich-95 protocol and were in remission. The mean serum antimüllerian hormone was 1.9±1.7 ng/mL before ovarian tissue cryopreservation. In all cases, ovarian tissue screening for leukemic cells was negative. Ovarian transplantation was performed laparoscopically with or without robotic assistance, after a median of 74.5 months (interquartile range, 41-120) after ovarian tissue cryopreservation. Ovarian function resumed in all patients after a median of 3.0 months (range, 2.5-4.0), and 2 women had 1 live birth each. The median graft longevity was 35.5 months (interquartile range, 18-57) after ovarian tissue transplantation. After a median follow-up of 51 months (interquartile range, 20-74), all patients remained relapse-free. In 1 patient, the graft was removed during cesarean delivery and was negative for immunochemical leukemia markers.Our long-term follow-up demonstrated no evidence of disease relapse after ovarian tissue transplantation in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation. This safety profile may be explained by the fact that these patients are induced into remission by nongonadotoxic induction chemotherapy before undergoing ovarian tissue cryopreservation. We propose that ovarian tissue cryopreservation should not be excluded as a fertility preservation option for young women with leukemia who are due to receive preconditioning chemotherapy before allogeneic hematopoietic stem cell transplantation." @default.
• W4386388908 created "2023-09-03" @default.
• W4386388908 creator A5001538252 @default.
• W4386388908 creator A5027679333 @default.
• W4386388908 creator A5033144183 @default.
• W4386388908 creator A5039267089 @default.
• W4386388908 creator A5061471763 @default.
• W4386388908 creator A5066648226 @default.
• W4386388908 creator A5069517795 @default.
• W4386388908 creator A5088345693 @default.
• W4386388908 date "2023-09-01" @default.
• W4386388908 modified "2023-10-12" @default.
• W4386388908 title "Safety of ovarian cryopreservation and transplantation in patients with acute leukemia: A case series" @default.
• W4386388908 cites W1988214254 @default.
• W4386388908 cites W1991037415 @default.
• W4386388908 cites W2046203713 @default.
• W4386388908 cites W2047285403 @default.
• W4386388908 cites W2066872086 @default.
• W4386388908 cites W2094487235 @default.
• W4386388908 cites W2158427154 @default.
• W4386388908 cites W2176253027 @default.
• W4386388908 cites W2770364500 @default.
• W4386388908 cites W2893362128 @default.
• W4386388908 cites W2908272071 @default.
• W4386388908 cites W2911326458 @default.
• W4386388908 cites W3035851024 @default.
• W4386388908 cites W3038918864 @default.
• W4386388908 cites W3105235048 @default.
• W4386388908 cites W3137565573 @default.
• W4386388908 cites W3173132937 @default.
• W4386388908 cites W3179152065 @default.
• W4386388908 cites W3212533243 @default.
• W4386388908 cites W4211047546 @default.
• W4386388908 cites W4231346141 @default.
• W4386388908 doi "https://doi.org/10.1016/j.ajog.2023.08.032" @default.
• W4386388908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37666382" @default.
• W4386388908 hasPublicationYear "2023" @default.
• W4386388908 type Work @default.
• W4386388908 citedByCount "0" @default.
• W4386388908 crossrefType "journal-article" @default.
• W4386388908 hasAuthorship W4386388908A5001538252 @default.
• W4386388908 hasAuthorship W4386388908A5027679333 @default.
• W4386388908 hasAuthorship W4386388908A5033144183 @default.
• W4386388908 hasAuthorship W4386388908A5039267089 @default.
• W4386388908 hasAuthorship W4386388908A5061471763 @default.
• W4386388908 hasAuthorship W4386388908A5066648226 @default.
• W4386388908 hasAuthorship W4386388908A5069517795 @default.
• W4386388908 hasAuthorship W4386388908A5088345693 @default.
• W4386388908 hasConcept C126322002 @default.
• W4386388908 hasConcept C142724271 @default.
• W4386388908 hasConcept C18597862 @default.
• W4386388908 hasConcept C2776863199 @default.
• W4386388908 hasConcept C2777408962 @default.
• W4386388908 hasConcept C2777904497 @default.
• W4386388908 hasConcept C2778461978 @default.
• W4386388908 hasConcept C2908647359 @default.
• W4386388908 hasConcept C2911091166 @default.
• W4386388908 hasConcept C518429986 @default.
• W4386388908 hasConcept C71924100 @default.
• W4386388908 hasConcept C99454951 @default.
• W4386388908 hasConceptScore W4386388908C126322002 @default.
• W4386388908 hasConceptScore W4386388908C142724271 @default.
• W4386388908 hasConceptScore W4386388908C18597862 @default.
• W4386388908 hasConceptScore W4386388908C2776863199 @default.
• W4386388908 hasConceptScore W4386388908C2777408962 @default.
• W4386388908 hasConceptScore W4386388908C2777904497 @default.
• W4386388908 hasConceptScore W4386388908C2778461978 @default.
• W4386388908 hasConceptScore W4386388908C2908647359 @default.
• W4386388908 hasConceptScore W4386388908C2911091166 @default.
• W4386388908 hasConceptScore W4386388908C518429986 @default.
• W4386388908 hasConceptScore W4386388908C71924100 @default.
• W4386388908 hasConceptScore W4386388908C99454951 @default.
• W4386388908 hasFunder F4320332161 @default.
• W4386388908 hasLocation W43863889081 @default.
• W4386388908 hasLocation W43863889082 @default.
• W4386388908 hasOpenAccess W4386388908 @default.
• W4386388908 hasPrimaryLocation W43863889081 @default.
• W4386388908 hasRelatedWork W1985568054 @default.
• W4386388908 hasRelatedWork W2012258839 @default.
• W4386388908 hasRelatedWork W2146821958 @default.
• W4386388908 hasRelatedWork W2150923376 @default.
• W4386388908 hasRelatedWork W221568964 @default.
• W4386388908 hasRelatedWork W2406209433 @default.
• W4386388908 hasRelatedWork W2412328276 @default.
• W4386388908 hasRelatedWork W2801702586 @default.
• W4386388908 hasRelatedWork W4206691674 @default.
• W4386388908 hasRelatedWork W4220972052 @default.
• W4386388908 isParatext "false" @default.
• W4386388908 isRetracted "false" @default.
• W4386388908 workType "article" @default.